Ken Griffin
RGNT

Ken Griffin’s Regentis Biomaterials RGNT Stock Holding History

Ken Griffin’s Portfolio RGNT Stock Details RGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,412
Closed -$70.2K – 14844
2025
Q4 		$70.2K Buy
+10,412
New +$71.4K ﹤0.01% 11864

Other funds holding RGNT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ken Griffin's RGNT Position: Q1 2026 in Review

Ken Griffin sold out of Regentis Biomaterials (RGNT) in Q1 2026, closing a stake of 10,412 shares — an estimated $70.2K sold.

Ken Griffin first reported a position in RGNT in Q4 2025 and held it in 1 quarter. The position peaked at $70.2K in Q4 2025. 3 funds tracked by Wall St. Rank hold RGNT as of Q1 2026.

  • Ken Griffin reported no remaining Regentis Biomaterials position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 10,412 Regentis Biomaterials shares in Q1 2026, an estimated $70.2K.
  • Ken Griffin first reported a position in Regentis Biomaterials in Q4 2025 and held it in 1 quarter.
  • Ken Griffin's Regentis Biomaterials position peaked at $70.2K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Regentis Biomaterials as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.